Glioma Grading Clinical and Mutation Features

Gliomas are the most common primary tumors of the brain. They can be graded as LGG (Lower-Grade Glioma) or GBM (Glioblastoma Multiforme) depending on the histological/imaging criteria. Clinical and molecular/mutation factors are also very crucial for the grading process. Molecular tests are expensive to help accurately diagnose glioma patients. In this dataset, the most frequently mutated 20 genes and 3 clinical features are considered from TCGA-LGG and TCGA-GBM brain glioma projects. The prediction task is to determine whether a patient is LGG or GBM with a given clinical and molecular/mutation features. The main objective is to find the optimal subset of mutation genes and clinical features for the glioma grading process to improve performance and reduce costs.

Characteristics
Tabular, Multivariate
Subject Area
Health and Medicine
Associated Tasks
Classification, Other

Attribute Type
--
# Instances
839
# Attributes
23

Introductory Paper

Hierarchical Voting-Based Feature Selection and Ensemble Learning Model Scheme for Glioma Grading with Clinical and Molecular Characteristics

By E. Tasci, Y. Zhuge, Harpreet Kaur, K. Camphausen, A. Krauze. 2022

Published in International Journal of Molecular Sciences

Provided by
University of California, Irvine


Creators
  • Erdal Tasci
  • Kevin Camphausen
  • Andra Valentina Krauze
  • Ying Zhuge

DOI

10.24432/C5R62J

Login to Download

New to AIM-AHEAD Connect?
Create an account!

Features

Attribute Name Role Type Demographic Description Units Missing Values
Grade Target Categorical Glioma grade class information (0 = "LGG"; 1 = "GBM") N/A no
Gender Feature Categorical Gender Gender (0 = "male"; 1 = "female") N/A no
Age_at_diagnosis Feature Continuous Age Age at diagnosis with the calculated number of days years no
Race Feature Categorical Race Race (0 = "white"; 1 = "black or african American"; 2 = "asian"; 3 = "american indian or alaska native") N/A no
IDH1 Feature Categorical isocitrate dehydrogenase (NADP(+))1 (0 = NOT_MUTATED; 1= MUTATED) N/A no
TP53 Feature Categorical tumor protein p53 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
ATRX Feature Categorical ATRX chromatin remodeler (0 = NOT_MUTATED; 1 = MUTATED) N/A no
PTEN Feature Categorical phosphatase and tensin homolog (0 = NOT_MUTATED; 1 = MUTATED) N/A no
EGFR Feature Categorical epidermal growth factor receptor (0 = NOT_MUTATED; 1 = MUTATED) N/A no
CIC Feature Categorical capicua transcriptional repressor (0 = NOT_MUTATED; 1 = MUTATED) N/A no
MUC16 Feature Categorical mucin 16, cell surface associated (0 = NOT_MUTATED; 1 = MUTATED) N/A no
PIK3CA Feature Categorical phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (0 = NOT_MUTATED; 1 = MUTATED) N/A no
NF1 Feature Categorical neurofibromin 1 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
PIK3R1 Feature Categorical phosphoinositide-3-kinase regulatory subunit 1 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
FUBP1 Feature Categorical far upstream element binding protein 1 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
RB1 Feature Categorical RB transcriptional corepressor 1 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
NOTCH1 Feature Categorical notch receptor 1 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
BCOR Feature Categorical BCL6 corepressor (0 = NOT_MUTATED; 1 = MUTATED) N/A no
CSMD3 Feature Categorical CUB and Sushi multiple domains 3 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
SMARCA4 Feature Categorical SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
GRIN2A Feature Categorical glutamate ionotropic receptor NMDA type subunit 2A (0 = NOT_MUTATED; 1 = MUTATED) N/A no
IDH2 Feature Categorical isocitrate dehydrogenase (NADP(+)) 2 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
FAT4 Feature Categorical FAT atypical cadherin 4 (0 = NOT_MUTATED; 1 = MUTATED) N/A no
PDGFRA Feature Categorical platelet-derived growth factor receptor alpha (0 = NOT_MUTATED; 1 = MUTATED) N/A no